Several studies reported that ETS1 supported cell growth (39), prevented apoptosis (40), and facilitated the invasion of melanoma (22); however, an early study demonstrated that the gene was widely expressed in benign and malignant melanocytes, and immunohistochemical analysis indicated that its expression had no significant association with the clinical outcome (41), supporting the results of the current study. Here, ETS1 is linked to melanoma.